MtoZ Biolabs - Model phip-seq-autoantibody-profiling-service -PhIP-Seq Autoantibody Profiling Service

Autoimmune disease research often involves broad and heterogeneous antibody responses, while the relevant autoantigens may not yet be fully defined. Targeted immunoassays remain useful when a limited set of established antigens needs to be examined, but they may provide limited coverage during exploratory studies.

Phage Immunoprecipitation Sequencing, or PhIP-Seq, provides a discovery-stage approach for profiling antibody reactivity across phage-displayed peptide libraries. It can support broad candidate screening, comparison of antibody reactivity patterns between study groups, and prioritization of candidate linear epitope-containing regions for follow-up research.

1. Comparative Autoantibody Profiling
PhIP-Seq may be used to compare autoantibody reactivity profiles between autoimmune disease cases and healthy controls, disease-control groups, or other biologically relevant populations. It can also support analyses across disease subtypes, activity states, clinically defined immune phenotypes, treatment groups, or longitudinal time points.

2. Discovery-Stage Candidate Screening
The service may be useful when relevant antibody targets remain uncertain or when initial targeted assays provide limited antigen coverage. PhIP-Seq can help identify candidate antibody-reactive peptides mapped to self-proteins, together with candidate linear epitope-containing regions, for subsequent biomarker research, mechanistic studies, or targeted validation.

1. Study Assessment
Before project initiation, sample type, sample condition, group design, antigen library needs, and research objectives can be evaluated. Serum and plasma are commonly used for antibody profiling, while other antibody-containing sample types can be assessed according to project requirements.

2. Validation-Oriented Support
PhIP-Seq is positioned as a discovery-stage screening and candidate-prioritization method. Candidate findings can be incorporated into a follow-up strategy using suitable peptide-based assays, full-length protein assays configured to preserve relevant antigenic context, cell-based assays, or other orthogonal immunoassays, depending on the nature of the target and the biological question.

PhIP-Seq Autoantibody Profiling Service helps autoimmune disease researchers move from broad antibody response screening toward a focused set of candidate peptide and antigen-related signals. MtoZ Biolabs can support antigen library strategy, sample evaluation, candidate prioritization, and validation-pathway planning based on the specific research objective.

MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The name of MtoZ represents “mass to charge ratio” in mass spectrometry analysis, as most of our services are provided based on our well-established mass spectrometry platforms. Our services allow for the rapid and efficient development of research projects, including protein analysis, proteomics, and metabolomics programs.

MtoZ Biolabs is specialized in quantitative multiplexed proteomics and metabolomics applications through the establishment of state-of-the-art mass spectrometry platforms, coupled with high-performance liquid chromatography technology. We are committed to developing efficient, and effective tools for addressing core bioinformatics problems. With a continuing focus on quality, MtoZ Biolabs is well equipped to help you with your needs in proteomics, metabolomics, bioinformatics, and biopharmaceutical research. Our ultimate aim is to provide more rapid, high-throughput, and cost-effective analysis, with exceptional data quality and minimal sample.

Email: [email protected]